Amgen Inc. (AMGN)

USD 258.78

(-2.7%)

Long Term Debt Summary of Amgen Inc.

  • Amgen Inc.'s latest annual long term debt in 2023 was 63.17 Billion USD , up 69.11% from previous year.
  • Amgen Inc.'s latest quarterly long term debt in 2024 Q2 was 57.11 Billion USD , down -4.9% from previous quarter.
  • Amgen Inc. reported annual long term debt of 37.35 Billion USD in 2022, up 12.44% from previous year.
  • Amgen Inc. reported annual long term debt of 33.22 Billion USD in 2021, up 0.99% from previous year.
  • Amgen Inc. reported quarterly long term debt of 57.11 Billion USD for 2024 Q2, down -4.9% from previous quarter.
  • Amgen Inc. reported quarterly long term debt of 56.85 Billion USD for 2024 Q3, down -0.46% from previous quarter.

Annual Long Term Debt Chart of Amgen Inc. (2023 - 1990)

Historical Annual Long Term Debt of Amgen Inc. (2023 - 1990)

Year Long Term Debt Long Term Debt Growth
2023 63.17 Billion USD 69.11%
2022 37.35 Billion USD 12.44%
2021 33.22 Billion USD 0.99%
2020 32.89 Billion USD 22.06%
2019 26.95 Billion USD -8.68%
2018 29.51 Billion USD -13.69%
2017 34.19 Billion USD 13.24%
2016 30.19 Billion USD 3.03%
2015 29.3 Billion USD -3.01%
2014 30.21 Billion USD 2.0%
2013 29.62 Billion USD 23.25%
2012 24.03 Billion USD 12.6%
2011 21.34 Billion USD 96.28%
2010 10.87 Billion USD 2.58%
2009 10.6 Billion USD 15.53%
2008 9.17 Billion USD -0.01%
2007 9.17 Billion USD 28.64%
2006 7.13 Billion USD 80.29%
2005 3.95 Billion USD 0.51%
2004 3.93 Billion USD 27.85%
2003 3.07 Billion USD 1.04%
2002 3.04 Billion USD 1266.68%
2001 223 Million USD 0.0%
2000 223 Million USD 0.0%
1999 223 Million USD 0.0%
1998 223 Million USD -2.62%
1997 229 Million USD 288.14%
1996 59 Million USD -66.7%
1995 177.2 Million USD -3.38%
1994 183.4 Million USD 1.21%
1993 181.2 Million USD 39.49%
1992 129.9 Million USD 227.2%
1991 39.7 Million USD -38.64%
1990 64.7 Million USD 0.0%

Peer Long Term Debt Comparison of Amgen Inc.

Name Long Term Debt Long Term Debt Difference
AstraZeneca PLC 23.22 Billion USD -172.027%
Biogen Inc. 7.18 Billion USD -778.801%
Gilead Sciences, Inc. 23.18 Billion USD -172.414%
MIRA Pharmaceuticals, Inc. - USD -Infinity%
Scilex Holding Company 17.03 Million USD -370659.479%
Scilex Holding Company 17.03 Million USD -370659.479%